Scott King, DO
Orthopaedic Surgery · Harrisburg, PANPI 1720082761
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $15,487 of the $20,134 with a category attached, or 76.9%. Nextstep Arthropedix, LLC accounts for 90.9% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $15,537, more than ten times the $201 reported in 2019.
Across 19 payments — averaging $1059.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nextstep Arthropedix, LLC$18K
- Novus Surgical Consultants$1K
- Stryker$149
- Zimmer Biomet$80
- Coloplast$50
- Maxx Orthopedics, Inc.$42
- plus $59 from 4 others
What the payments were for
- Royalty or licence$15,48777%
- Consulting fees$2,70013%
- Travel & lodging$1,4477%
- Food & beverage$5002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nextstep Arthropedix, LLC | 5 | $18,306 |
| Novus Surgical Consultants | 2 | $1,447 |
| Stryker | 3 | $149 |
| Zimmer Biomet | 3 | $80 |
| Coloplast | 1 | $50 |
| Maxx Orthopedics, Inc. | 1 | $42 |
| Smith+Nephew | 1 | $22 |
| Merck | 1 | $17 |
| Amgen | 1 | $12 |
| Heraeus Medical, LLC. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iNSitu Hip System$18,187
- MAKO$101
How this compares
$20,134 in reported general payments places this provider in the 80th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 184 | $484 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 86 | $470 |
| Cephalexin | 301 | $400 |
| Diclofenac Sodium | 15 | $348 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $199 |
| Methylprednisolone | 19 | $75 |
| Clindamycin Hcl | 39 | $51 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Harrisburg
- Walter PeppelmanHarrisburg$211K
- John GrandrimoHarrisburg$176K
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.